Variant report
Variant | esv2554931 |
---|---|
Chromosome Location | chr7:27294688-27297872 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7794193 | chr7:27294701-27294702 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs191742262 | chr7:27294702-27294703 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138155247 | chr7:27294772-27294773 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371750152 | chr7:27294789-27294790 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs571488171 | chr7:27294801-27294802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538866429 | chr7:27294826-27294827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370688478 | chr7:27294829-27294830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557195542 | chr7:27294831-27294832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575854949 | chr7:27294836-27294837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543357339 | chr7:27294839-27294840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115617823 | chr7:27294869-27294870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs80328314 | chr7:27294874-27294875 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113243822 | chr7:27294893-27294894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34954505 | chr7:27295043-27295044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs36041172 | chr7:27295083-27295084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183705613 | chr7:27295090-27295091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568929777 | chr7:27295105-27295106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs71539510 | chr7:27295244-27295245 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs58342196 | chr7:27295253-27295254 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs80022819 | chr7:27295260-27295261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188183605 | chr7:27295282-27295283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs61129362 | chr7:27295287-27295288 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs567538165 | chr7:27295330-27295331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111361779 | chr7:27295342-27295343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375780383 | chr7:27295377-27295378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201305122 | chr7:27295379-27295380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373246942 | chr7:27295381-27295382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs57113847 | chr7:27295397-27295398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374025057 | chr7:27295400-27295401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs35066924 | chr7:27295401-27295402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs66655839 | chr7:27295402-27295403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs56727209 | chr7:27295403-27295404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11760569 | chr7:27295404-27295405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs71910218 | chr7:27295412-27295413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs70994636 | chr7:27295422-27295423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11760573 | chr7:27295440-27295441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528496645 | chr7:27295468-27295469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546658224 | chr7:27295481-27295482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571420845 | chr7:27295486-27295487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs538804100 | chr7:27295487-27295488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557273828 | chr7:27295495-27295496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569481204 | chr7:27295497-27295498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183264933 | chr7:27295731-27295732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555276902 | chr7:27295732-27295733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147201450 | chr7:27295802-27295803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541044984 | chr7:27295835-27295836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11971251 | chr7:27295858-27295859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs370762298 | chr7:27295877-27295878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577816660 | chr7:27295882-27295883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs35786897 | chr7:27295886-27295887 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
abnormal development | 18461090 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Lung cancer | 17086460 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:27294000-27294800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr7:27294400-27295000 | Enhancers | Osteobl | bone |
3 | chr7:27294600-27294800 | Bivalent Enhancer | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr7:27294800-27296000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr7:27295000-27296000 | Weak transcription | Osteobl | bone |
6 | chr7:27296000-27296200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr7:27296000-27296400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr7:27296000-27296600 | Enhancers | Osteobl | bone |
9 | chr7:27296200-27297000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr7:27296200-27297600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr7:27296600-27297000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
12 | chr7:27296600-27297000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr7:27297600-27297800 | Flanking Bivalent TSS/Enh | ES-WA7 Cell Line | embryonic stem cell |
14 | chr7:27297600-27298400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr7:27297800-27298000 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |